Max Delbrück Center
Register
Register
Register

ExpertiseUpdated on 19 November 2025

Tailored Biomarker Solutions for your Clinical Programs

CEO at CheckImmune GmbH

Berlin, Germany

About

Selection/validation of drug lead candidates

Application of a broad panel of customized and off-the-shelf biomarker tests using cutting-edge technologies for lead candidate selection.

Phase 0 studies

Proof-of-concept studies on biosamples from target patient populations (phase 0) to confirm selected biomarker test portfolios for following therapy monitoring.

Therapy monitoring 

Therapy monitoring in clinical trials to check safety, PD/PK, patient stratfication with a wide range of validated assays as well as newly developed customized methods.

Data analysis and scientific & medical interpretation

CheckImmune is backed by a world-renowned team of experts with years of academic and commercial experience in the field of biomarkers.

Field

  • DISEASE AREA | Cancer
  • DISEASE AREA | Inflammation / Autoimmune Diseases
  • DISEASE AREA | Infectious Diseases
  • DISEASE AREA | Metabolic Diseases
  • MEDICINE | Biomarker Discovery
  • MEDICINE | Early Detection
  • MEDICINE | Diagnostics
  • MEDICINE | Cell Therapy
  • MEDICINE | RNA-based Therapy
  • MEDICINE | Therapy Monitoring
  • TECHNOLOGY | (Single-cell) multi-omics

Organisation

CheckImmune GmbH

Diagnostics/Laboratory

Berlin, Germany

Similar opportunities

  • Expertise

    New Approach Methodologies (NAM) Training Program

    • TECHNOLOGY | Other
    • DISEASE AREA | Cancer
    • DISEASE AREA | Other
    • MEDICINE | Gene Therapy
    • MEDICINE | Cell Therapy
    • MEDICINE | Drug Screening
    • TECHNOLOGY | Bioengineering
    • MEDICINE | RNA-based Therapy
    • MEDICINE | Drug Target Discovery
    • DISEASE AREA | Metabolic Diseases
    • DISEASE AREA | Infectious Diseases
    • TECHNOLOGY | Personalized disease models
    • DISEASE AREA | Inflammation / Autoimmune Diseases

    Marty Steiger

    Application Scientist at Dynamic42 GmbH

    Germany

  • Expertise

    DNA & RNA Library Preparation

    • MEDICINE | Other
    • TECHNOLOGY | Other
    • DISEASE AREA | Cancer
    • DISEASE AREA | Other
    • MEDICINE | Diagnostics
    • MEDICINE | Gene Therapy
    • MEDICINE | Liquid Biopsy
    • MEDICINE | Drug Screening
    • MEDICINE | Early Detection
    • MEDICINE | RNA-based Therapy
    • MEDICINE | Biomarker Discovery
    • MEDICINE | Drug Target Discovery
    • DISEASE AREA | Infectious Diseases
    • DISEASE AREA | Cardiovascular Diseases

    Ismahen Ammar

    Technical Sales Specialist at Illumina GmbH

    Berlin, Germany

  • Investment

    Selective Inhibitors of Genotoxic Stress Induced NFκB Pathway for Cancer Therapy

    • Disease Area
    • Seed & Development
    • Biomedical Research, Medicine, Human Health

    Beatrice Pöschel

    Technologie-Managerin at Max Delbrück Center for Molecular Medicine

    Berlin, Germany